Patient Guide: AD-006: Placebo-controlled trial of blarcamesine in early Alzheimer's disease within the Access AD program

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTAD-006
Status: ANNOUNCED
Condition: Alzheimer's disease, Early Alzheimer's disease
Phase: PHASE4

Loading interactive enrollment tools...

The full interactive experience will load momentarily